About
Olof Mollstedt is the co-founder and co-CEO of Alixia, a San Francisco biotech company developing therapies that target the tumor ecosystem to address cancer drug resistance. According to Alixia, he previously worked as a research scientist at NASA Ames Supercomputing Division and later served as Chief Manufacturing Officer at Ambryx, with additional experience at Nestle's innovation and industrial performance teams. His profile is centered on biotech company building and scientific operations rather than investing.
Areas of interest
biotechoncologycancer therapeuticstumor microenvironmentdrug discoveryagingimmunologycomputational chemistrybiophysics